1.Therapeutic vaccination with lentiviral vector in HBV persistent mice and two inactive HBsAg carriers, Journal of Hepatology, 2024, 80(1): 31-40 .

2.Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated with Nucleos(t)ide Analogues, The Journal of Infectious Diseases, 2023, 227(5): 675-685 .

3.Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection, The Journal of Infectious Diseases, 2023.

4.Visualizing in situ viral replication across the natural history of chronic HBV infection, Hepatology Communications, 2023

5.Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients, Journal of Hepatology, 2018, 68(1): 16-24 .

6.Natural history of serum HBV-RNA in chronic HBV infection, Journal of Viral Hepatitis, 2018, 25(9): 1038-1047 .

7.IFN-stimulated gene LY6E in monocytes regulates the CD14/TLR4 pathway but inadequately restrains the hyperactivation of monocytes during chronic HIV-1 infection., The Journal of Immunology, 2014, 193(8): 4125-4136.

8.Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu, Journal of Virology, 2014, 88(10): 5356-5368 .

9.MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+T cells, PNAS, 2013, 47(110):19083-19088 .

10.Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine, Clinical Infectious Disease, 2012 Jan 1;54(1):17-24.

11.Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus, Emerging Infectious Diseases, 2013 Oct;19(10):1685-7.